An update on statins: Pleiotropic effect performed in intracerebral hemorrhage

We read with interest the recent article by Chung et al. [1] published in this issue of Atherosclerosis, in which the authors demonstrated that patients with intracerebral hemorrhage (ICH), who continued statin therapy, had better all-cause mortality outcomes compared with those who did not continue statin therapy. Although the authors have some possible explanations for the mechanism via the pleiotropic effect of statins, such as anti-oxidative, BBB protection and anti-inflammation, experimental evidence of continue statin therapy is still lacking.

Source: Atherosclerosis - January 25, 2019 Category: Cardiology Authors: Qianwei Chen, Jianbo Zhang, Hua Feng, Zhi Chen Tags: Correspondence Source Type: research